Last updated: 2026-09-16 09:46:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Vivani Medical, Inc. (VANI) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1,23, with a market capitalisation of $113,66M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,92 to $1,92. This page covers its latest market performance, valuation, price trends and company information.
$113,66M | |
$1,26 | |
$7,80 | |
$0,75 | |
$1,26 | |
206,23K | |
477,65K | |
-- | |
$1,92 | |
$0,92 | |
-- | |
-- |
Vivani Medical, Inc. (VANI) is trading at $1,30 in pre-market trading as of 2026-09-15 23:37:00, up 2,78% ($0,03) from the previous close of $1,26
Pre-market trading shows how investors are pricing VANI before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Vivani Medical, Inc. (VANI) moved from $1,49 to $1,23, representing a decline of 17,79% ($0,26).
The stock traded between $1,21 and $1,52 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 298,92 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 30,3%
VANI is currently trading at $1,23, placing it 30,3% of the way from its 52-week low of $0,92 to its 52-week high of $1,92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 36 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Vivani Medical, Inc. (VANI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.